Clinical Trials
3 trialsNCT04370834 2025-02-04
Tocilizumab for Patients With Cancer and COVID-19 Disease
National Cancer Institute (NCI)
Phase 2 Terminated
NCT04358406 2023-11-28
Rhu-pGSN for Severe Covid-19 Pneumonia
BioAegis Therapeutics Inc.
Phase 2 Completed
NCT01502072 2021-02-15
Respiratory Syncytial Virus - RSV Protocol
M.D. Anderson Cancer Center
Phase 2 Completed